ImmunoGen Inc (IMGN)
US45253H1014 - Common Stock
| TTM (2023-9-30) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -73.52M | -222.93M | -139.30M | -44.37M | -104.13M | |||
| Depreciation Amortization | 1.72M | 1.78M | 2.02M | 2.10M | 4.03M | |||
| Change In Working Capital | -150.87M | -25.60M | -23.55M | -4.56M | 25.72M | |||
| Interest Paid | N/A | 0.00 | 50.00K | 100.00K | 100.00K | |||
| Other non cash items | 24.78M | 16.94M | -8.58M | -31.79M | -13.99M | |||
| OPERATING CASH FLOW | -197.89M | -229.80M | -169.42M | -78.62M | -88.37M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -1.88M | -1.36M | -1.43M | -920.00K | -2.85M | |||
| Other Investing Activity | N/A | N/A | N/A | 1.43M | 2.31M | |||
| INVESTING CASH FLOW | -1.88M | -1.36M | -1.43M | 510.00K | -530.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | -1.10M | N/A | N/A | |||
| Stock Issued/Repurchased | 423.98M | 27.55M | 157.80M | 195.74M | 2.87M | |||
| Other Financing Activity | N/A | N/A | 199.05M | N/A | 0.00 | |||
| FINANCING CASH FLOW | 495.80M | 27.55M | 355.74M | 195.74M | 2.87M | |||
| CHANGE IN CASH | 296.03M | -203.61M | 184.89M | 117.63M | -86.03M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -197.89M | -229.80M | -169.42M | -78.62M | -88.37M | |||
| Capital Expenditure | -1.88M | -1.36M | -1.43M | -920.00K | -2.85M | |||
| FREE CASH FLOW | -199.77M | -231.16M | -170.85M | -79.54M | -91.22M | |||
All data in USD